Long-Term Study Confirms Lasting Quality-of-Life Benefits From BioProtect Balloon Spacer in Prostate Cancer Radiotherapy

BioProtect, dedicated to prostate cancer radiation therapy, reported long-term results from a study demonstrating sustained quality-of-life improvements for prostate cancer patients treated with its BioProtect Balloon Spacer during radiotherapy. The biodegradable balloon, positioned between the prostate and rectum, continues to show reduced rectal toxicity and maintained urinary and bowel function scores well beyond treatment completion.

The findings add to growing evidence supporting rectal spacers in precision radiation oncology. BioProtect’s hydrogel-free design offers simplified placement and full resorption within six months. The study supports broader adoption of protective spacing technologies as standard of care in prostate radiotherapy.

Posted by MedCloudInsider Editors on 11/10/2025